KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Non-Current Deffered Revenue (2019 - 2025)

Teladoc Health (TDOC) has disclosed Non-Current Deffered Revenue for 7 consecutive years, with $9.1 million as the latest value for Q4 2025.

  • Quarterly Non-Current Deffered Revenue fell 6.61% to $9.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.1 million through Dec 2025, down 6.61% year-over-year, with the annual reading at $9.1 million for FY2025, 6.61% down from the prior year.
  • Non-Current Deffered Revenue hit $9.1 million in Q4 2025 for Teladoc Health, down from $11.2 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $15.0 million in Q1 2024 to a low of $2.7 million in Q1 2021.
  • Historically, Non-Current Deffered Revenue has averaged $8.4 million across 5 years, with a median of $10.0 million in 2024.
  • Biggest five-year swings in Non-Current Deffered Revenue: surged 322.18% in 2023 and later crashed 31.7% in 2025.
  • Year by year, Non-Current Deffered Revenue stood at $3.8 million in 2021, then soared by 211.79% to $12.0 million in 2022, then rose by 13.96% to $13.6 million in 2023, then dropped by 28.17% to $9.8 million in 2024, then dropped by 6.61% to $9.1 million in 2025.
  • Business Quant data shows Non-Current Deffered Revenue for TDOC at $9.1 million in Q4 2025, $11.2 million in Q3 2025, and $10.7 million in Q2 2025.